FDA Inspection
Nuvisan GmbHNuvisan GmbH – FDA Inspection, Jun 8, 2018
Record Details
This FDA Inspection record concerns Nuvisan GmbH, with an inspection on June 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nuvisan GmbH
- Inspection Date
- June 8, 2018
- Product Type
- Drugs
View Company Profile
ID · 65187590-1574-44e2-9346-9623acaaf1c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1060551
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Nuvisan GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2024 | Not classified | Office of Inspections and Investigations | |
| February 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nuvisan GmbH
- FDA Inspection 1288880 - 2024-10-17
- FDA Inspection 1160058 - 2020-02-06
- FDA Inspection 891842 - 2014-07-25
- FDA Inspection 788970 - 2012-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.